Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

  1. Home

  • Sunday, Oct 26th
    10:30 AM - 11:30 AM Central Time
    26S23: The Doctor 'Nose' Best: Ear, Nose, and Throat Manifestations in ANCA-Associated Vasculitis
    Location: S102
    Moderator: Curry Koening, MD, MS – University of Texas Dell Medical School
    Moderator: Brendan Denvir, MD (he/him/his) – Johns Hopkins School of Medicine
    Session Coordinator: Curry Koening, MD, MS – University of Texas Dell Medical School
     CE: 1.00
  • Sunday, Oct 26th
    10:30 AM - 11:00 AM Central Time
    The ENT Manifestations of ANCA-Associated Vasculitis
    Location: S102
    Speaker: Mark Zacharek, MD – University of Michigan
  • Sunday, Oct 26th
    11:00 AM - 11:30 AM Central Time
    Treatment of Ear, Nose, and Throat Manifestations in ANCA-Associated Vasculitis
    Location: S102
    Speaker: Lindsay S. Lally, MD – Hospital for Special Surgery
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Vasculitis – ANCA-Associated Poster I
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Vasculitis – Non-ANCA-Associated & Related Disorders Poster I
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0731: The Efficacy of Leflunomide in the Treatment of Giant Cell Arteritis: A Systematic Review and Meta-Analysis
    Location: Hall F1
    Abstract Poster Presenter: Jean-Paul Makhzoum, MD, FRCPC, MSc, FACP – Vasculitis Clinic, Canadian Network for Research on Vasculitides, Hopital du Sacre-Coeur de Montreal
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0732: Blocking GM-CSF receptor alpha with mavrilimumab reduces production of growth factors involved in vascular remodeling in an ex-vivo model of temporal artery culture from patients with giant-cell arteritis (GCA)
    Location: Hall F1
    Abstract Poster Presenter: Maria Cid, MD (she/her/hers) – Hospital Clinic Barcelona. University of Barcelona
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0733: Cerebrovascular Accidents in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Pranathi Bandarupalli, MD (she/her/hers) – Mercy St Vincent Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0734: Glucocorticoid Exposure and Comorbidity Profile in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis: a multi-country cohort study
    Location: Hall F1
    Abstract Poster Presenter: Valeria Jordan M., MD – Novartis
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0735: A Real-world Study from the Greater Paris Clinical Data Warehouse
    Location: Hall F1
    Abstract Poster Presenter: Aïcha Kante, MD, MSc – Université Paris Cité
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0736: Effectiveness of Tocilizumab in strokes in patients with giant cell arteritis. Spanish multicenter study of clinical practice
    Location: Hall F1
    Abstract Poster Presenter: Ana Serrano-Combarro, MD – Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, Inmunopathology group, Santander
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0737: Effectiveness and Safety of Janus Kinase Inhibitors in Giant Cell Arteritis. Real-World Clinical Practice Study and Literature Review
    Location: Hall F1
    Abstract Poster Presenter: Ana Serrano-Combarro, MD – Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, Inmunopathology group, Santander
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0738: Real World Steroid Burden, Treatment Patterns, and Rheumatologists' Perceptions on Advanced Therapy in Giant Cell Arteritis
    Location: Hall F1
    Abstract Poster Presenter: Anisha Dua, MD, MPH – Northwestern University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0739: Tocilizumab in Giant Cell Arteritis with ischemic vs non-ischemic manifestations
    Location: Hall F1
    Abstract Poster Presenter: CARMEN SECADA-GÓMEZ, MD – HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0740: Intravenous versus subcutaneous administration of Tocilizumab in aortitis associated with giant cell arteritis: multicenter open-label study of 196 patients
    Location: Hall F1
    Abstract Poster Presenter: CARMEN SECADA-GÓMEZ, MD – HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0741: Characteristics of African American vs. Non-African American Patients with Giant Cell Arteritis: A Retrospective Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Dana Nachawati, DO – University Hospitals Cleveland Medical Center/Case Western Reserve University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0742: Exploring Racial Variation in the Clinical Manifestations of Giant Cell Arteritis: A Retrospective Single-Center Study
    Location: Hall F1
    Abstract Poster Presenter: Dana Nachawati, DO – University Hospitals Cleveland Medical Center/Case Western Reserve University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0743: Giant Cell Arteritis Relapse After Treatment with Two Months of Prednisone and 12 Months of Tocilizumab
    Location: Hall F1
    Abstract Poster Presenter: David O'Dea, BA (he/him/his) – Massachusetts General Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0744: Age and Sex Influence on Clinical Manifestations of Giant Cell Arteritis: Results from the ARTESER Registry
    Location: Hall F1
    Abstract Poster Presenter: Delia Fernandez-Lozano, MD – Hospital Universitario y Politécnico La Fe
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0745: Prevalence and Clinical Significance of Low ESR and CRP in Giant Cell Arteritis: A Population Based Study
    Location: Hall F1
    Abstract Poster Presenter: Eugenio De Miguel, MD;PhD – Hospital Universitario La Paz
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0746: Impact of Frailty on Mortality in GCA and PMR: A Retrospective Cohort
    Location: Hall F1
    Abstract Poster Presenter: Fatima Hassan, MD – Medical College of Wisconsin
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0747: Patterns of Macrophage Polarization Induced by Serum from Patients with Giant Cell Arteritis and Takayasu’s Arteritis
    Location: Hall F1
    Abstract Poster Presenter: Irene Carrión-Barberà, MD, PhD – University of Washington
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0748: Does The Number Of Arteries Affected At The Disease Onset Predict Relapses Of Giant Cell Arteritis?
    Location: Hall F1
    Abstract Poster Presenter: Iztok HOLC, MD, PhD (he/him/his) – University Medical Center Maribor
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0749: Prevalence and characteristics of subclinical Polymyalgia Rheumatica in patients with Giant Cell Arteritis
    Location: Hall F1
    Abstract Poster Presenter: Javier Narvaez, PhD – Hospital Universitario de Bellvitge
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0750: Fibrinogen as a biomarker in the diagnosis of giant cell arteritis and detection of flares
    Location: Hall F1
    Abstract Poster Presenter: Jonathan Miller, MBBS BSc (Hons) MRCP (UK) PGCert (MedEd) – St Vincent's University Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0751: Impact of Treatment with Upadacitinib on Biomarkers Identified by Proteomics in Giant Cell Arteritis
    Location: Hall F1
    Abstract Poster Presenter: Lisa Christ, MD – Inselspital, University Bern, Switzerland
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0752: Characterization of patients with polymyalgia rheumatica in the ARTESER giant cell arteritis cohort
    Location: Hall F1
    Abstract Poster Presenter: Maite Silva-Diaz, MD – Complexo Hospitalario Universitario A Coruña
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0753: Incidence of Ischemic Vision Loss Among Patients with Polymyalgia Rheumatica and Giant Cell Arteritis
    Location: Hall F1
    Abstract Poster Presenter: Mary Peng, MD, BA (she/her/hers) – Medical College of Wisconsin
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0754: Is There a Seasonal Pattern in Giant Cell Arteritis? Revisiting the Evidence in a Large Monocentric Cohort of 1203 patients
    Location: Hall F1
    Abstract Poster Presenter: Milena Bond, MD – South Tyrol Health Trust
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0755: Sex Differences in Subtypes of Vascular Involvement and Clinical Manifestations in Giant Cell Arteritis
    Location: Hall F1
    Abstract Poster Presenter: Natalia López Juanes, MD – Hospital Universitario La Paz
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0756: Stroke Characteristics in Giant Cell Arteritis and Takayasu Arteritis: A Multicenter Cohort Study of 108 Patients
    Location: Hall F1
    Abstract Poster Presenter: Omar Dhrif, MD – CHU Dijon Bourgogne
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0757: The role of Methotrexate in the treatment of Giant Cell Arteritis: data from the ARTESER registry.
    Location: Hall F1
    Abstract Poster Presenter: Pablo Francisco Muñoz Martínez, MD – Hospital Universitario y Politécnico La Fe
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0758: Association Between Baseline IL-6 Levels and the Clinical Phenotype of Giant Cell Arteritis
    Location: Hall F1
    Abstract Poster Presenter: Raquel Ugena García, MD – Hospital Universitari Germans Trias i Pujol
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0759: Distinct differences between giant cell arteritis diagnosed by fluorodeoxyglucose (FDG) positron emission tomography (PET) versus temporal artery biopsy-a comparative cohort study
    Location: Hall F1
    Abstract Poster Presenter: Sehreen Mumtaz, MD, MBBS – Mayo Clinic Florida
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0760: The Efficacy Of Targeted Therapies In Giant Cell Arteritis: A Systematic Review and Meta-Analysis
    Location: Hall F1
    Abstract Poster Presenter: Sema Kaymaz-Tahra, MD – Bahcesehir University Faculty of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0762: Relapse rate, predictors of relapses and impact of introduction of interleukin-6-receptor inhibition on relapse rate in GCA- Data from the large REATS cohort from six vasculitis centers
    Location: Hall F1
    Abstract Poster Presenter: Verena Schoenau, MD (she/her/hers) – - Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0763: Diagnostic Utility of Temporal Artery Biopsy in Giant Cell Arteritis: A Single Center Experience
    Location: Hall F1
    Abstract Poster Presenter: Wendy Perdomo, MD – Thomas Jefferson University Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0764: Frequency of large vessel vasculitis in giant cell arteritis with and without adventiitis of temporal artery - Is the presence of temporal arteritis sufficient to diagnose giant cell arteritis?-
    Location: Hall F1
    Abstract Poster Presenter: Yoichiro Akiyama, MD – Meiyo Immunology and Rheumatology Clinic
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0717: Circulating Bacterial sRNAs are Altered in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Location: Hall F1
    Abstract Poster Presenter: Christopher Xavier, BS – Meharry Medical College
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0719: A Combined Transcriptomics and Proteomics Approach to Identify Immune Signatures in ANCA-Associated Glomerulonephritis
    Location: Hall F1
    Abstract Poster Presenter: Ivana Stojkic, MD, MMSc – Nationwide Children's Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0724: Risk of Drug Induced Liver Injury with Use of Avacopan in ANCA Vasculitis - Results from Real-World Data
    Location: Hall F1
    Abstract Poster Presenter: Milad Heydari-Kamjani, DO – University Hospitals Cleveland Medical Center/ Case Western Reserve University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0723: Neutrophil and Eosinophil Extracellular Traps in Eosinophilic Granulomatosis with Polyangiitis: Phenotype-based Characterization and Response to Mepolizumab
    Location: Hall F1
    Abstract Poster Presenter: Michele Moretti, MD – University of Pisa, Rheumatology Unit
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0711: Analytical Performance of a Novel, Fully Automated Multiplexed Microarray Immunoassay Prototype for the Simultaneous Detection of Autoantibodies to GBM, PR3, and MPO: A Multicenter Evaluation
    Location: Hall F1
    Abstract Poster Presenter: Gerber Gomez, MD, MSc (he/him/his) – AliveDx Suisse SA
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0728: Incidence and Clinical Characteristics of ANCA-Associated Vasculitis: A Nationwide Study in Spain
    Location: Hall F1
    Abstract Poster Presenter: Susana Romero-Yuste, MD, PhD, MSc – University Hospital Complex of Pontevedra
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0713: Differentiating Primary Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis from Secondary Forms
    Location: Hall F1
    Abstract Poster Presenter: Adil Vural, MD – Cleveland Clinic
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0729: Anca-associated Vasculitis - Does the Type Matter?
    Location: Hall F1
    Abstract Poster Presenter: Tamanna Vinodkumar Mohta, MD (she/her/hers) – Hemet Global Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0718: Incidence of Venous Thromboembolism in Patients with ANCA-Associated Vasculitides – a Nationwide Registry-Based Study from Sweden
    Location: Hall F1
    Abstract Poster Presenter: Hanna Lindberg, PhD, MD (she/her/hers) – Uppsala University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0730: Levels of Disease Activity and Their Relationship With Health-Related Quality of Life In ANCA-Associated Vasculitis Patients: Data from the Almenara Vasculitis Cohort
    Location: Hall F1
    Abstract Poster Presenter: Victor Pimentel-Quiroz, MD (he/him/his) – Universidad Científica del Sur
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0715: Supervised machine learning algorithm to identify patients with eosinophilic granulomatosis with polyangiitis in France
    Location: Hall F1
    Abstract Poster Presenter: Benjamin Terrier, MD, PhD (he/him/his) – Cochin Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0726: Real-World Avacopan Use in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Insights from United States Claims Data on Outcomes and Adherence
    Location: Hall F1
    Abstract Poster Presenter: Sebastian E. Sattui, MD, MS – University of Pittsburgh
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0714: Factors Associated With Depression And Anxiety In ANCA-Associated Vasculitis Patients: Data From The Almenara Vasculitis Cohort
    Location: Hall F1
    Abstract Poster Presenter: Alvaro Oyarce-Calderón, Sr, MD (he/him/his) – Hospital Nacional Guillermo Almenara Irigoyen
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0716: Utility of Follow-Up Cardiac Magnetic Resonance Imaging In Patients With Eosinophilic Granulomatosis With Polyangiitis
    Location: Hall F1
    Abstract Poster Presenter: Chelsea Cheng, MD (she/her/hers) – University of Toronto
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0721: Pulmonary Manifestations of Granulomatosis with Polyangiitis and Microscopic Polyangiitis
    Location: Hall F1
    Abstract Poster Presenter: Mats Junek, MD, MSc – McMaster University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0720: Current State of Racial, Ethnic, Sex, and Geographical Diversity in ANCA-associated vasculitis and Giant Cell Arteritis Trials
    Location: Hall F1
    Abstract Poster Presenter: Manuel Carpio Tumba, MD – University of Pittsburgh
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0722: Estimating two-year risk of relapse in individuals with ANCA-associated vasculitis in a randomized controlled trial of plasma exchange and glucocorticoids
    Location: Hall F1
    Abstract Poster Presenter: Mats Junek, MD, MSc – McMaster University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0725: Sinonasal Symptom Profiles Associated with Disease Activity in an International Cohort of Patients with ANCA-Associated Vasculitis
    Location: Hall F1
    Abstract Poster Presenter: Rennie Rhee, MD, MS – University of Pennsylvania
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0712: Effects of Bacterial Secretome on Nasal Epithelial Cell Gene Expression in ANCA-Associated Vasculitis
    Location: Hall F1
    Abstract Poster Presenter: A. Nikolai von Krusenstiern, MD, PhD – Hospital of the University of Pennsylvania
  • Sunday, Oct 26th
    3:00 PM - 4:30 PM Central Time
    26S57: Flying Solo: Recognizing and Treating Single-Organ Vasculitis
    Location: W196A-C
    Moderator: Adam Kilian, MD – Saint Louis University
    Moderator: Rennie Rhee, MD, MS – University of Pennsylvania
    Session Coordinator: Curry Koening, MD, MS – University of Texas Dell Medical School
    Session Coordinator: Adam Kilian, MD – Saint Louis University
     CE: 1.50
  • Sunday, Oct 26th
    3:00 PM - 3:30 PM Central Time
    Cutaneous Vasculitis
    Location: W196A-C
    Speaker: Robert Micheletti, MD – Perelman School of Medicine, University of Pennsylvania
  • Sunday, Oct 26th
    3:30 PM - 4:00 PM Central Time
    CNS Vaculitis
    Location: W196A-C
    Speaker: Rula A. Hajj-Ali, MD – Cleveland Clinic
  • Sunday, Oct 26th
    4:00 PM - 4:30 PM Central Time
    Isolated Aortitis
    Location: W196A-C
    Speaker: Tanaz Kermani, MD, MS – University of California Los Angeles
  • Monday, Oct 27th
    10:00 AM - 11:30 AM Central Time
    27M15: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders I: GCA from Bench to Bedside
    Location: S103
    Abstract Moderator: Audra Horomanski, MD, RhMSUS – Stanford University
    Abstract Moderator: Ora Singer, MD, MS – University of Michigan
     CE: 0.00
  • Monday, Oct 27th
    10:00 AM - 10:15 AM Central Time
    0891: MEthotrexate versus TOcilizumab for treatment of Giant cell Arteritis (METOGiA trial): a multicenter, randomized, controlled trial.
    Location: S103
    Presenting Author: Maxime SAMSON, MD,PhD (he/him/his) – CHU Dijon Bourgogne
  • Monday, Oct 27th
    10:15 AM - 10:30 AM Central Time
    0892: Relapse and Immune Dysregulation in Giant Cell Arteritis Are Linked to Mosaic Loss of the Y Chromosome
    Location: S103
    Presenting Author: Simon Petzinna, MD – University Hospital Bonn
  • Monday, Oct 27th
    10:30 AM - 10:45 AM Central Time
    0893: Transcriptomic insights into GCA compared to clinically diverse controls: Inflammation, Aging, Therapeutic Targets and the role of SPP1 in the temporal artery
    Location: S103
    Presenting Author: Ingrid Lindquist, MD – Veterans Affairs
  • Monday, Oct 27th
    10:45 AM - 11:00 AM Central Time
    0894: Altered B Cell Subpopulations in Giant Cell Arteritis
    Location: S103
    Presenting Author: Maria-Eugenia Miranda-Carus, MD,PhD (she/her/hers) – Hospital Universitario La Paz
  • Monday, Oct 27th
    11:00 AM - 11:15 AM Central Time
    0895: Impact of Glucocorticoid Tapering in Giant Cell Arteritis: Analysis From the SELECT-GCA Trial
    Location: S103
    Presenting Author: FRANK BUTTGEREIT, MD – Charité University Medicine Berlin
  • Monday, Oct 27th
    11:15 AM - 11:30 AM Central Time
    0896: Does complement product C5a and its receptor C5a receptor 1 play a role in giant-cell arteritis?
    Location: S103
    Presenting Author: Maria Cid, MD (she/her/hers) – Hospital Clinic Barcelona. University of Barcelona
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    Vasculitis – ANCA-Associated Poster II
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    Vasculitis – Non-ANCA-Associated & Related Disorders Poster II
    Location: Hall F1
     CE: 0.00
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1612: Window of opportunity with tocilizumab therapy in giant cell arteritis. Multicenter study of 471 patients of clinical practice
    Location: Hall F1
    Abstract Poster Presenter: Adrián Martín-Gutiérrez, -None- – Hospital Universitario Marques de Valdecilla, IDIVAL
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1613: Switching From Reference Tocilizumab to Biosimilar in Giant Cell Arteritis: Effectiveness and Safety in a Multicenter Study of 38 Patients
    Location: Hall F1
    Abstract Poster Presenter: Adrián Martín-Gutiérrez, -None- – Hospital Universitario Marques de Valdecilla, IDIVAL
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1614: A Systematic Literature Review to Inform the EULAR Recommendations for the Management of Polymyalgia Rheumatica and Large Vessel Vasculitis: Focus on Referral and Diagnosis
    Location: Hall F1
    Abstract Poster Presenter: Alice Bartoletti, MD – ASST Gaetano Pini CTO
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1615: Prevalence of Clinical and Laboratory Manifestations of Patients with Deficiency of Adenosine Deaminase 2 (DADA2): A Systematic Review and Meta-Analysis
    Location: Hall F1
    Abstract Poster Presenter: Athanasios Vassilopoulos, MD – Brown University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1616: Short-Course Prednisone and Methotrexate in Polymyalgia Rheumatica: A Potential Therapeutic Approach
    Location: Hall F1
    Abstract Poster Presenter: Edoardo Conticini – Università di Siena
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1617: Evaluating Familiarity and Knowledge Gaps in Polymyalgia Rheumatica Among Public Health Professionals
    Location: Hall F1
    Abstract Poster Presenter: Erik Stone, MA – Global Healthy Living Foundation
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1618: Use of JAK inhibitors in patients with refractory Takayasu arteritis: A worldwide retrospective study
    Location: Hall F1
    Abstract Poster Presenter: Fatma Alibaz-Oner, MD – MARMARA UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DIVISION OF RHEUMATOLOGY
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1619: Systemic Immune-Inflammation Index Is Superior to Neutrophil-to-Lymphocyte Ratio for Assessing Disease Activity in Polymyalgia Rheumatica and Giant Cell Arteritis
    Location: Hall F1
    Abstract Poster Presenter: Gaston Ghio, Sr, MD – Hospital Universitari Mutua de Terrassa
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1620: Correlation Between Histopathological Findings and PET-CT Results in Patients With Inflammatory Aortitis
    Location: Hall F1
    Abstract Poster Presenter: Guillem Verdaguer Faja, MD, -None- – Hospital de la Santa Creu i Sant Pau
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1621: Temporal Association Between Viral Positivity Rates and Kawasaki Disease Incidence at a Large Tertiary Center
    Location: Hall F1
    Abstract Poster Presenter: Jessica Nguyen, MD, MEd – Cook Children's Medical Center
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1622: Defective CD4+ regulatory T cells in active Takayasu arteritis patients can be improved by efficiency treatment of tofacitinib
    Location: Hall F1
    Abstract Poster Presenter: jing luo, MD (she/her/hers) – the first affiliated hospital of xi'an jiaotong university
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1623: The Association of Calprotectin with Vascular Injury and Remodeling in Clinically-Isolated Aortitis
    Location: Hall F1
    Abstract Poster Presenter: Katarina Kmetova, PhD, MSc – Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1624: Disease activity status in Takayasu's arteritis influences the angiogenic potential of patient-derived endothelial cells
    Location: Hall F1
    Abstract Poster Presenter: Luciana Yamamoto de Almeida, PhD, MSc – National Institutes of Health
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1625: Factor VIII as a Potential Biomarker of Disease Activity in Relapsing Polychondritis
    Location: Hall F1
    Abstract Poster Presenter: Marcela Ferrada, MD – University of Maryland
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1627: A Systematic Literature Review to Inform the 2025 EULAR Recommendations for Management of Polymyalgia Rheumatica and Large Vessel Vasculitis: Management of Disease Including Relapse and Complications
    Location: Hall F1
    Abstract Poster Presenter: Mrinalini Dey, MRCP, MA, MBBCH – Centre for Rheumatic Diseases, King's College London
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1628: Characterization of non-GCA, non-Takayasu Aortitis in a Single Health System Cohort
    Location: Hall F1
    Abstract Poster Presenter: Nuzhat Batool, MBBS – NYU Grossman Long Island School of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1629: Real-World Effectiveness of Interleukin-6 Receptor Inhibitors Compared to Methotrexate in Steroid-Refractory Frail Patients with Polymyalgia Rheumatica
    Location: Hall F1
    Abstract Poster Presenter: Stefano Fiore, MD – Sanofi Genzyme & Regeneron
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1630: Validation of the classification algorithm using the modified 2022 ACR/EULAR giant cell arteritis classification criteria and Japanese Takayasu arteritis diagnostic criteria
    Location: Hall F1
    Abstract Poster Presenter: Takahiko Sugihara, MD, PhD – Toho University School of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1631: New Arterial Damage in Takayasu’s Arteritis
    Location: Hall F1
    Abstract Poster Presenter: Tanaz Kermani, MD, MS – University of California Los Angeles
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1632: PET/CT-Based Distribution of Arterial Involvement and Its Association With Clinical Outcomes in Takayasu Arteritis
    Location: Hall F1
    Abstract Poster Presenter: Tokio Katakura, MD – Department of Rheumatology, Tohoku University Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1606: One Year Real-World Effectiveness with Avacopan in Granulomatosis with Polyangiitis and Microscopic Polyangiitis in a Large Healthcare System
    Location: Hall F1
    Abstract Poster Presenter: Naomi Patel, MD, MPH – Massachusetts General Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1610: Early Mepolizumab Initiation Enables High Glucocorticoid and Immunosuppressant Discontinuation Rates in EGPA: A Retrospective Cohort Study of 35 Patients
    Location: Hall F1
    Abstract Poster Presenter: Takashi Yamane, MD;PhD – Kakogawa Central City Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1602: Biomarkers of Innate Immune Activation to Identify Non-Response to Rituximab in Granulomatosis with Polyangiitis
    Location: Hall F1
    Abstract Poster Presenter: Irene Carrión-Barberà, MD, PhD – University of Washington
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1607: Antibiotic Prophylaxis During Treatment of Anca-associated Vasculitis with Rituximab: Data from a Multicenter Cohort
    Location: Hall F1
    Abstract Poster Presenter: Natasha Le Blanc, MD, BSc – McGill University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1598: Use of JAK Inhibitors in Medium- and Small-Sized Vasculitides: a Retrospective Multicenter Study
    Location: Hall F1
    Abstract Poster Presenter: Caterina Ricordi, MD – AUSL-IRCCS of Reggio Emilia and University of Modena and Reggio Emilia
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1609: A Multicenter Prospective Longitudinal Observational Study to Determine Safety of Extended Treatment with Rituximab in Maintaining Remission in Patients with ANCA Associated Vasculitis (AAV) - An Interim Analysis
    Location: Hall F1
    Abstract Poster Presenter: Ravi Kumar U, DM – Christian Medical College
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1597: Effectiveness and Safety of Rituximab Biosimilars in Small Vessel Vasculitis: a Systematic Literature Review
    Location: Hall F1
    Abstract Poster Presenter: Caitlyn Kanters, MD (she/her/hers) – McGill University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1599: Cyclophosphamide versus Rituximab in the treatment of Anca-associated Vasculitis: Adverse events and Relapses
    Location: Hall F1
    Abstract Poster Presenter: Fabricio Benavides, MD – Hospital Universitario Marqués de Valdecilla
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1593: Comparison of rituximab induction and maintenance regimens in ANCA-associated vasculitis: PK/PD modelling approach in real-world patients
    Location: Hall F1
    Abstract Poster Presenter: Benjamin Terrier, MD, PhD (he/him/his) – Cochin Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1604: Impact and risk factors of anti-rituximab antibodies in small-vessel vasculitis: a multicenter retrospective study
    Location: Hall F1
    Abstract Poster Presenter: lucas khellaf, MD, MMSc (he/him/his) – Sorbonne University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1601: Obinutuzumab Induces and Maintains Remission in Refractory or Relapsing ANCA-Associated Vasculitis – A Case Series
    Location: Hall F1
    Abstract Poster Presenter: Helen Au, MBBS – Klinik für Innere Medizin, Rheumatologie und Immunologie, medius Klinik Kirchheim
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1626: A Delphi Exercise Informing the Development of Criteria to Measure Response to Treatment in Giant Cell Arteritis
    Location: Hall F1
    Abstract Poster Presenter: Medha Soowamber, MD – Mount Sinai Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1611: Effectiveness of Avacopan and Its Impact on Serum Calprotectin in MPA/GPA Patients Receiving Rituximab-Based Remission Induction: A Single-Center Study
    Location: Hall F1
    Abstract Poster Presenter: Yusuke Ushio, MD – Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1595: Subcordal Stenosis is a Glucocorticoid-Responsive Manifestation of Granulomatosis with Polyangiitis
    Location: Hall F1
    Abstract Poster Presenter: Brendan Denvir, MD (he/him/his) – Johns Hopkins School of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1603: SGLT-2 Inhibitors are Associated with Lower Risk of End Stage Renal Disease (ESRD) and Lower Mortality in ANCA-associated Vasculitis With Kidney Involvement
    Location: Hall F1
    Abstract Poster Presenter: Julia Foos, BA – University of Toledo College of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1596: GPA-Associated Tracheobronchial Stenosis: Immunosuppressant Use and Dilation Frequency
    Location: Hall F1
    Abstract Poster Presenter: Brendan Denvir, MD (he/him/his) – Johns Hopkins School of Medicine
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1608: Efficacy of Anti-IL-5/R Therapies on Specific Disease Manifestations of Eosinophilic Granulomatosis with Polyangiitis
    Location: Hall F1
    Abstract Poster Presenter: Peter Merkel, MD, MPH – University of Pennsylvania
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1605: Combined Anti-IL-5/IL-5R and Dupilumab Therapy in Eosinophilic Granulomatosis with Polyangiitis: A European Retrospective Study
    Location: Hall F1
    Abstract Poster Presenter: Miriam Guerini, MBChB – IRCCS Policlinico San Matteo, University of Pavia
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1594: Two-Year Efficacy of Anti-Interleukin-5/Receptor Therapies According to Anti-Neutrophil Cytoplasmic Antibodies Status in Patients with Eosinophilic Granulomatosis with Polyangiitis
    Location: Hall F1
    Abstract Poster Presenter: Benjamin Terrier, MD, PhD (he/him/his) – Cochin Hospital
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1600: Real-world clinical effectiveness of Benralizumab for Eosinophilic Granulomatosis with Polyangiitis: a National multicenter study
    Location: Hall F1
    Abstract Poster Presenter: Fabricio Benavides, MD – Hospital Universitario Marqués de Valdecilla
  • Monday, Oct 27th
    10:30 AM - 12:30 PM Central Time
    1592: Mepolizumab to Benralizumab Switch in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
    Location: Hall F1
    Abstract Poster Presenter: Adrien Cottu, MD – Cochin Hospital
  • Monday, Oct 27th
    3:00 PM - 4:00 PM Central Time
    27M67: CARE to Test Your Knowledge: Refractory ANCA Vasculitis
    Location: W375D-E
    Moderator: Sebastian E. Sattui, MD, MS – University of Pittsburgh
    Moderator: Brendan Antiochos, MD – Johns Hopkins
    Session Coordinator: Michael Toprover, MD – New York University Langone Health
     CE: 1.00
  • Monday, Oct 27th
    3:00 PM - 4:00 PM Central Time
    Refractory ANCA Vasculitis
    Location: W375D-E
    Speaker: Anisha Dua, MD, MPH – Northwestern University
  • Tuesday, Oct 28th
    10:00 AM - 11:00 AM Central Time
    28T25: Great Debate: Giant Cell Arteritis: Ultrasound vs. Biopsy
    Location: W375B
    Moderator: Mats Junek, MD, MSc – McMaster University
    Moderator: Brendan Antiochos, MD – Johns Hopkins
    Session Coordinator: Anca Askanase, MD, MPH – Columbia University Medical Center
     CE: 1.00
  • Tuesday, Oct 28th
    10:00 AM - 10:30 AM Central Time
    Ultrasound Should Replace Biopsy for the Diagnosis of Giant Cell Arteritis
    Location: W375B
    Speaker: Wolfgang Schmidt, MD, MACR – Waldfriede Hospital Berlin, Rheumatology
  • Tuesday, Oct 28th
    10:30 AM - 11:00 AM Central Time
    Ultrasound Should Not Replace Biopsy for the Diagnosis of Giant Cell Arteritis
    Location: W375B
    Speaker: Peter Grayson, MD, MSc – National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
  • Tuesday, Oct 28th
    10:00 AM - 11:30 AM Central Time
    28T13: Abstracts: Vasculitis – ANCA-Associated
    Location: S103
    Abstract Moderator: Jean-Paul Makhzoum, MD, FRCPC, MSc, FACP – Vasculitis Clinic, Canadian Network for Research on Vasculitides, Hopital du Sacre-Coeur de Montreal
    Abstract Moderator: Luc Mouthon, MD, PhD – Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Cochin University Hospital, Université Paris Cité, AP-HP
     CE: 0.00
  • Tuesday, Oct 28th
    10:00 AM - 10:15 AM Central Time
    1764: Development and Validation of a Simulation Model for Induction of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Location: S103
    Presenting Author: Naomi Patel, MD, MPH – Massachusetts General Hospital
  • Tuesday, Oct 28th
    10:15 AM - 10:30 AM Central Time
    1765: Maintenance of remission with rituximab versus azathioprine in newly diagnosed or relapsing eosinophilic granulomatosis with polyangiitis. A prospective, randomized, controlled, double-blind trial
    Location: S103
    Presenting Author: Xavier Puéchal, MD, PhD (he/him/his) – National Referral Center for Rare Systemic Autoimmune Diseases
  • Tuesday, Oct 28th
    10:30 AM - 10:45 AM Central Time
    1766: Clinical Impact of Incomplete B-cell Depletion in ANCA-Associated Vasculitis Patients Receiving Maintenance Rituximab Therapy: a Retrospective Study
    Location: S103
    Presenting Author: Caterina Ricordi, MD – AUSL-IRCCS of Reggio Emilia and University of Modena and Reggio Emilia
  • Tuesday, Oct 28th
    10:45 AM - 11:00 AM Central Time
    1767: Identification of C3 complement fragments in lesional tissues in ANCA-associated vasculitis
    Location: S103
    Presenting Author: Peter Merkel, MD, MPH – University of Pennsylvania
  • Tuesday, Oct 28th
    11:00 AM - 11:15 AM Central Time
    1768: TREM-1 and TREM-2 Define Inflammatory and Protective Axes in ANCA-Associated Glomerulonephritis
    Location: S103
    Presenting Author: Lea Dionet, PhD – INSERM
  • Tuesday, Oct 28th
    11:15 AM - 11:30 AM Central Time
    1769: Classification of Relapses of Eosinophilic Granulomatosis with Polyangiitis After Two-Years of Treatment with Anti-Interleukin-5/Receptor Therapy
    Location: S103
    Presenting Author: Christian Pagnoux, MD, MSc, MPH – Mount Sinai Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Vasculitis – ANCA-Associated Poster III
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Vasculitis – Non-ANCA-Associated & Related Disorders Poster III
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2524: Rituximab in the Treatment of Susac Syndrome: Single Center Descriptive Study with a Large Susac Cohort
    Location: Hall F1
    Abstract Poster Presenter: Adam Brown, MD;BS – Cleveland Clinic
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2525: Point-of-Care Risk Factors for Systemic Disease in Patients Presenting with Small Vessel Vasculitis of the Skin
    Location: Hall F1
    Abstract Poster Presenter: Arjun Mahajan, MS – Harvard Medical School
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2526: Infection Risk Associated with Steroid-Sparing Therapies in GCA, PMR, and ANCA-Associated Vasculitis: A Systematic Review
    Location: Hall F1
    Abstract Poster Presenter: Divya Sudireddy, MBBS – Boston Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2527: Safety Profile and Impaired Humoral Response to the Recombinant Herpes Zoster Vaccine in Behçet’s Syndrome Patients under Immunosuppression: a Prospective, Randomized, Placebo-Controlled Trial
    Location: Hall F1
    Abstract Poster Presenter: Eduardo Borba, PhD – Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2528: Broad Screening of the Human Proteome Identifies a Cassette of Six Autoantigens that Distinguishes IgG4-Related Disease
    Location: Hall F1
    Abstract Poster Presenter: Federica Bonaso, MD – University of Brescia/MGH
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2529: IgG4-Related Disease Paravertebral and Ureteropelvic Mass Presentations are Linked to Specific Disease Features
    Location: Hall F1
    Abstract Poster Presenter: Federica Bonaso, MD – University of Brescia/MGH
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2530: Broad Screening of Inflammation-Associated Proteins Identifies Serum CCL19 and CCL2 as Versatile Biomarkers of Disease Activity in IgG4-Related Disease
    Location: Hall F1
    Abstract Poster Presenter: Federica Bonaso, MD – University of Brescia/MGH
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2531: Coronary periarteritis in IgG4-Related Disease
    Location: Hall F1
    Abstract Poster Presenter: Georges El Hasbani, MD – Mayo Clinic
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2532: Temporal arteritis revealing eosinophilic diseases: A multicenter retrospective study, literature review, and combined cluster analysis
    Location: Hall F1
    Abstract Poster Presenter: Julie Mérindol, MD (she/her/hers) – CHU de Nice
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2533: Patterns of skin lesion transcriptomics in different forms of vasculitis
    Location: Hall F1
    Abstract Poster Presenter: Karyssa Stonick, BS – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2534: Frequency of Ocular and Gastrointestinal Lesions Is Increased in Japanese Behçet’s Disease Patients with HLA-B61
    Location: Hall F1
    Abstract Poster Presenter: Koichi Sugihara, MD – Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2535: Behçet’s syndrome: distinct features in 344 pediatric and adult patients in a non-endemic region
    Location: Hall F1
    Abstract Poster Presenter: Lucia Campos, MD, PhD (she/her/hers) – University of Sao Paulo Medical School
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2536: High Levels of Fatigue and Poor Sleep Quality in Behçet Disease: a Cross-sectional Study from a Non-endemic Area
    Location: Hall F1
    Abstract Poster Presenter: Mateus Nunes, MD – University of Campinas (UNICAMP)
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2537: Variation in Treatment Approaches in IgA-Vasculitis Among Pediatricians and Pediatric rheumatologists: A Cross-Sectional International Survey
    Location: Hall F1
    Abstract Poster Presenter: Merav Heshin Bekenstein, MD – Tel Aviv Medical Center Israel
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2538: Comparative Study of Two Classification Criteria Sets in Real Clinical Practice in Behçet’s Disease
    Location: Hall F1
    Abstract Poster Presenter: Rafael Gálvez Sánchez, Sr, MD – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2539: Patient-reported outcomes in patients with polymyalgia rheumatica under rheumatology care: baseline data from the ENRICH-PMR cohort
    Location: Hall F1
    Abstract Poster Presenter: Sebastian E. Sattui, MD, MS – University of Pittsburgh
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2540: Monocyte-to-High-Density Lipoprotein Cholesterol Ratio as a Clinical Marker of Gastrointestinal Involvement in Behçet Syndrome
    Location: Hall F1
    Abstract Poster Presenter: Seong Ryul Kwon, MD, PhD – Inha University Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2541: Development of Severity Classification Criteria for Introduction of Infliximab for Chronic Pogressive Neuro-Behçet's Disease
    Location: Hall F1
    Abstract Poster Presenter: Shunsei Hirohata, MD – Nobuhara Clinic
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2542: A Rule Based NLP Pipeline for Glucocorticoid Exposure
    Location: Hall F1
    Abstract Poster Presenter: Simran Nimal, MBBS – Mayo Clinic
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2543: Severe Visual Impairment in Behçet Syndrome in Time: A Comparison of Four Time Periods
    Location: Hall F1
    Abstract Poster Presenter: Sinem Nihal Esatoglu, MD (she/her/hers) – Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2544: Diagnostic value of vein wall thickness measurement for patients with suspected Behçet syndrome
    Location: Hall F1
    Abstract Poster Presenter: Sinem Nihal Esatoglu, MD (she/her/hers) – Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2545: Prevalence, Clinical Correlations and Outcomes of Cryoglobulinemic Vasculitis: a Retrospective Monocentric Study (2013–2023)
    Location: Hall F1
    Abstract Poster Presenter: Valeria Manfrè, MD – Division of Rheumatology, Department of Medicine, University of Udine, Italy; Department of Medicine, Division of Rheumatology, University of Wisconsin - Madison, WI
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2546: Diagnostic Journey, Clinical Burden, And Quality Of Life Of Patients With IGg4-Related Disease: Results Of A Cross-Sectional Survey Of Patients And Physicians In The United States
    Location: Hall F1
    Abstract Poster Presenter: Yasmin Hernandez-Barco, MD – Massachusetts General Hospital, Harvard Medical School
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2512: Contribution of the CALLY index at diagnosis to early prediction of all-cause mortality in patients with ANCA-associated vasculitis
    Location: Hall F1
    Abstract Poster Presenter: Jang Woo Ha, MD – Yonsei university college of medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2523: Predictors of Glucocorticoid-Free Clinical Remission at Week 48 in Newly Diagnosed Microscopic Polyangiitis and Granulomatosis with Polyangiitis: from nation-wide registry in Japan (J-CANVAS)
    Location: Hall F1
    Abstract Poster Presenter: Yusuke Ushio, MD – Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2513: Beyond Clinical trials in Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review of effectiveness and safety data derived from real-world evidence of Mepolizumab 300 mg
    Location: Hall F1
    Abstract Poster Presenter: Maria Cid, MD (she/her/hers) – Hospital Clinic Barcelona. University of Barcelona
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2507: Reporting of infectious and hepatic adverse events with avacopan: insights from the World Health Organization pharmacovigilance database (VigiBase)
    Location: Hall F1
    Abstract Poster Presenter: Camille Mettler, MD – APHP, Service de Médecine Interne, Hôpital Bichat
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2519: A Disproportionality Analysis of FDA Adverse Event Reporting System (FAERS) Events for Avacopan
    Location: Hall F1
    Abstract Poster Presenter: Shiamak Cooper, MD – Rochester General Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2505: Avacopan is Not Associated With An Increased Risk of Infection Compared to Glucocorticoids in Patients with ANCA-Associated Vasculitis
    Location: Hall F1
    Abstract Poster Presenter: Beatriz Maria Franco Hondermann, MD (she/her/hers) – Loyola University Medical Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2518: Impact of psychiatric comorbidity on disease outcomes in ANCA-associated vasculitis: A multi-center retrospective cohort study
    Location: Hall F1
    Abstract Poster Presenter: Saloni Patel, BS (she/her/hers) – Johns Hopkins University School of Medicine
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2506: Timing, Management, and Outcomes of Venous Thromboembolic Events in ANCA-Associated Vasculitis: A Retrospective Cohort Study
    Location: Hall F1
    Abstract Poster Presenter: Bruno Marchetti, MD – Internal Medicine, Turin
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2508: Patient-Reported Outcomes in ANCA-Associated Vasculitis: Early Findings from a Prospective Real-World Cohort
    Location: Hall F1
    Abstract Poster Presenter: Colebrook Johnson, BA – Massachusetts General Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2514: Comparison of Demographics and Outcomes of Inpatient Hospitalization of Severe Asthma Patients with Eosinophilic Granulomatosis with Polyangitis. A Study on the National Inpatient Sample Database
    Location: Hall F1
    Abstract Poster Presenter: Prakriti Subedi, MD – St. Barnabas Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2520: Evolution in Risk Stratification for Renal Outcomes in ANCA-Associated Vasculitides Using Established Scores and Histopathological Criteria in a Large European Cohort
    Location: Hall F1
    Abstract Poster Presenter: Thomas Neumann, MD – Kantonsspital St. Gallen
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2521: DANGER Score as Predictor of Mortality in ANCA-Associated Vasculitis with or without Glomerulonephritis: Data from the Almenara Vasculitis Cohort
    Location: Hall F1
    Abstract Poster Presenter: Victor Pimentel-Quiroz, MD (he/him/his) – Universidad Científica del Sur
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2510: Impact of ANCA specificity on risk of severe infection occurrence in ANCA-associated vasculitis.
    Location: Hall F1
    Abstract Poster Presenter: Gregory Pugnet, MD,PhD (he/him/his) – CHU Toulouse Rangueil Service de Medecine Interne et Immunologie Clinique
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2522: Clinical Outcomes and Prognostic Impact of Cardiac and Cerebrovascular Involvement in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Study
    Location: Hall F1
    Abstract Poster Presenter: Yuko Shirota, MD., PhD., – Tohoku Medical and Pharmaceutical University / Department of Hematology and Rheumatology
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2504: Variables Associated with In-Hospital Mortality in Adult Eosinophilic Granulomatosis with Polyangiitis from the National Inpatient Sample Database 2017-2021
    Location: Hall F1
    Abstract Poster Presenter: Anuya Natu, MBBS – John H Stroger, Jr. Hospital of Cook County
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2517: Predictors for Mortality in Patients Who Received Plasmapheresis for Diffuse Alveolar Hemorrhage in ANCA-Associated Vasculitis
    Location: Hall F1
    Abstract Poster Presenter: Sai Shanmukha Sreeram Pannala, MD (he/him/his) – Northwell Health/Staten Island University Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2516: Mortality Trends in Primary Systemic Vasculitis in the United States (1999–2023)
    Location: Hall F1
    Abstract Poster Presenter: Sabah Mohib, MBBS – Dow Medical College
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2511: The SHIPE index: A tertile-based approach to predict end-stage kidney disease in ANCA-associated vasculitis
    Location: Hall F1
    Abstract Poster Presenter: HYUNSUE DO, MD – Kangwon national university hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2515: The Association Between Neurologic Involvement and Cumulative Damage in ANCA-Associated Vasculitis
    Location: Hall F1
    Abstract Poster Presenter: Ruoning (Lemon) Ni, MD, RhMSUS (she/her/hers) – University of Iowa
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2509: Predicting future relapse with proteomics in ANCA-Associated Vasculitis
    Location: Hall F1
    Abstract Poster Presenter: Evan Barnes, MD, MS – Massachusetts General Hospital
  • Tuesday, Oct 28th
    1:00 PM - 2:00 PM Central Time
    28T46: Philip Hench Memorial Lecture
    Location: W196A-C
    Moderator: Vikas Majithia, MD, MBBS, MPH – Mayo Clinic Florida
    Moderator: Cory Perugino, DO – Massachusetts General Hospital
    Session Coordinator: Gregory Gardner, MD – University of Washington
     CE: 1.00
  • Tuesday, Oct 28th
    1:00 PM - 2:00 PM Central Time
    IgG4-Related Disease: From Bedside to Bench and Back to Bedside
    Location: W196A-C
    Speaker: John Stone, MD, MPH – Massachusetts General Hospital , Harvard Medical School
  • Wednesday, Oct 29th
    11:30 AM - 1:00 PM Central Time
    29W13: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders II
    Location: W187A-C
    Abstract Moderator: Andy Abril, MD – Mayo Clinic
    Abstract Moderator: Matthew Koster, MD, RhMSUS – Mayo Clinic
     CE: 0.00
  • Wednesday, Oct 29th
    11:30 AM - 11:45 AM Central Time
    2699: Cutaneous IgA Vasculitis: Emulation of a Target Trial from a European Multicentric Retrospective Study
    Location: W187A-C
    Presenting Author: Elena Biancamaria Mariotti, MD, MS – University of Florence
  • Wednesday, Oct 29th
    11:45 AM - 12:00 PM Central Time
    2700: Neutrophil Transcriptomics and Maturation Pathways in VEXAS Syndrome
    Location: W187A-C
    Presenting Author: Benjamin Turturice, MD;PhD – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
  • Wednesday, Oct 29th
    12:00 PM - 12:15 PM Central Time
    2701: Ophthalmic Manifestations of Relapsing Polychondritis
    Location: W187A-C
    Presenting Author: Akash Gupta, MD – Duke University School of Medicine
  • Wednesday, Oct 29th
    12:15 PM - 12:30 PM Central Time
    2702: Diagnostic Performance of Vascular Ultrasound in Giant Cell Arteritis – A Single Center Experience
    Location: W187A-C
    Presenting Author: Ruoning (Lemon) Ni, MD, RhMSUS (she/her/hers) – University of Iowa
  • Wednesday, Oct 29th
    12:30 PM - 12:45 PM Central Time
    2703: Longitudinal Changes on Cranial Magnetic Resonance Imaging in Relapsing Giant Cell Arteritis
    Location: W187A-C
    Presenting Author: Ruoheng Zeng, BS – Perelman School of Medicine
  • Wednesday, Oct 29th
    12:45 PM - 1:00 PM Central Time
    2704: Complete metabolic response on PET/CT in giant-cell arteritis-related large vessel vasculitis : comparison of two strategies using glucocorticoids or glucocorticoids + tocilizumab
    Location: W187A-C
    Presenting Author: Hubert de Boysson, MD,PhD – Caen university Hospital